Stock Rich List
Nasdaq: ORMP

Oramed Pharmaceuticals insiders

The officers, directors and 10% owners of Oramed Pharmaceuticals Inc. who hold the most stock, valued at the live ORMP price.

$3.69
ORMP today −$200K (−5.14%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their ORMP stock
$48.9M
Market value
$160M
Held by ranked insiders
30.5%

Insiders by value of ORMP holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Nadav KidronPresident and CEO5,457,505$20.1M12.6%5151st
2Miriam KidronChief Scientific Officer2,149,554$7.9M4.94%10419th
3Benjamin ShapiroDirector2,097,050$7.7M4.82%10621st
4Joshua HexterCOO & CBO1,927,130$7.1M4.43%11271st
5Avraham GabayChief Financial Officer1,460,076$5.4M3.36%13671st
6Yadin RozovDirector155,320$573K0.36%4300th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Oramed Pharmaceuticals; see each profile for the filing.